A detailed history of Bank Of America Corp transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Bank Of America Corp holds 25,165 shares of VOR stock, worth $25,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,165
Previous 28,642 12.14%
Holding current value
$25,416
Previous $67,000 62.69%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.0 - $2.2 $3,477 - $7,649
-3,477 Reduced 12.14%
25,165 $25,000
Q1 2024

May 15, 2024

SELL
$1.8 - $2.85 $44,818 - $70,962
-24,899 Reduced 46.5%
28,642 $67,000
Q4 2023

Feb 14, 2024

BUY
$1.66 - $2.63 $57,759 - $91,510
34,795 Added 185.61%
53,541 $120,000
Q2 2023

Aug 14, 2023

SELL
$3.09 - $5.33 $109,942 - $189,641
-35,580 Reduced 65.49%
18,746 $57,000
Q1 2023

May 12, 2023

BUY
$4.68 - $6.96 $235,797 - $350,672
50,384 Added 1278.13%
54,326 $292,000
Q4 2022

Feb 10, 2023

BUY
$3.77 - $7.43 $8,456 - $16,665
2,243 Added 132.02%
3,942 $26,000
Q3 2022

Nov 14, 2022

BUY
$3.9 - $5.52 $951 - $1,346
244 Added 16.77%
1,699 $7,000
Q2 2022

Aug 12, 2022

SELL
$3.89 - $6.44 $24,168 - $40,011
-6,213 Reduced 81.03%
1,455 $7,000
Q1 2022

May 16, 2022

SELL
$6.04 - $12.23 $38,607 - $78,174
-6,392 Reduced 45.46%
7,668 $47,000
Q4 2021

Feb 08, 2022

SELL
$11.32 - $18.02 $70,059 - $111,525
-6,189 Reduced 30.56%
14,060 $163,000
Q3 2021

Nov 15, 2021

BUY
$12.24 - $20.38 $15,997 - $26,636
1,307 Added 6.9%
20,249 $318,000
Q2 2021

Sep 13, 2021

BUY
$18.65 - $38.78 $353,268 - $734,570
18,942 New
18,942 $353,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $38.4M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.